Tumour base transection during shave biopsy remains a clinically significant problem when diagnosing melanoma. In this issue of the Journal, de Menezes and her colleagues1 report that the number of… Click to show full abstract
Tumour base transection during shave biopsy remains a clinically significant problem when diagnosing melanoma. In this issue of the Journal, de Menezes and her colleagues1 report that the number of shave biopsies in Victoria has more than doubled over the past 10 years, a major concern for clinicians and their patients. Excisional biopsy is the preferred method for assessing melanoma, as invasion is often impossible to predict preoperatively; excision minimises the risks of delayed or misdiagnosis and inaccurate tumour staging.
               
Click one of the above tabs to view related content.